Investigator Initiated Pilot Study of Microarray Directed Therapy for Diffuse Large B-Cell Lymphoma Using Genasense With CHOP-R.

Trial Profile

Investigator Initiated Pilot Study of Microarray Directed Therapy for Diffuse Large B-Cell Lymphoma Using Genasense With CHOP-R.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2012

At a glance

  • Drugs Cyclophosphamide; Doxorubicin; Oblimersen; Prednisone; Rituximab; Vincristine
  • Indications Diffuse large B cell lymphoma
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 12 Oct 2012 Planned End Date changed from 1 Dec 2013 to 1 Oct 2022 as reported by ClinicalTrials.gov record.
    • 12 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 02 Jun 2010 Additional trial centre, investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top